Deschedule Cannabis, Psilocybin, MDMA, LSD, and Ayahuasca to Allow Unrestricted Research

The Issue

I am a passionate advocate for the potential medicinal and therapeutic benefits of certain psychoactive substances. After extensive research into the history of cannabis, psilocybin (magic mushrooms), MDMA (ecstasy), LSD (acid), and ayahuasca, I have come to believe that these substances were unfairly demonized due to propaganda rather than scientific evidence.

These substances are currently classified as Schedule I drugs under the Controlled Substances Act in the United States. This classification means they are considered to have no accepted medical use and a high potential for abuse. However, this classification was not based on rigorous scientific research or empirical evidence.

Emerging studies suggest that these substances may have significant therapeutic potential. For example, recent studies indicate that psilocybin could be effective in treating depression and anxiety disorders while MDMA has shown promise in treating post-traumatic stress disorder.

It is crucial that we deschedule these substances so we can conduct worry-free, completely legal research into their effects and potentially unlock their therapeutic benefits. By doing so, we would be basing our drug policies on science-backed facts rather than outdated propaganda.

We must act now to ensure our laws reflect current scientific understanding and allow for further exploration of these potentially life-changing compounds. Please sign this petition urging lawmakers to deschedule cannabis, psilocybin, MDMA, LSD ,and ayahuasca. 

56

The Issue

I am a passionate advocate for the potential medicinal and therapeutic benefits of certain psychoactive substances. After extensive research into the history of cannabis, psilocybin (magic mushrooms), MDMA (ecstasy), LSD (acid), and ayahuasca, I have come to believe that these substances were unfairly demonized due to propaganda rather than scientific evidence.

These substances are currently classified as Schedule I drugs under the Controlled Substances Act in the United States. This classification means they are considered to have no accepted medical use and a high potential for abuse. However, this classification was not based on rigorous scientific research or empirical evidence.

Emerging studies suggest that these substances may have significant therapeutic potential. For example, recent studies indicate that psilocybin could be effective in treating depression and anxiety disorders while MDMA has shown promise in treating post-traumatic stress disorder.

It is crucial that we deschedule these substances so we can conduct worry-free, completely legal research into their effects and potentially unlock their therapeutic benefits. By doing so, we would be basing our drug policies on science-backed facts rather than outdated propaganda.

We must act now to ensure our laws reflect current scientific understanding and allow for further exploration of these potentially life-changing compounds. Please sign this petition urging lawmakers to deschedule cannabis, psilocybin, MDMA, LSD ,and ayahuasca. 

Supporter Voices

Petition Updates